Market Capitalization (Millions $) |
140 |
Shares
Outstanding (Millions) |
14 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
0 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
0 |
Ibere Pharmaceuticals
Ibere Pharmaceuticals is a pharmaceutical company that focuses on the research, development, and commercialization of innovative therapies. It operates in the biopharmaceutical industry and aims to provide solutions for various medical conditions and diseases. Ibere Pharmaceuticals conducts clinical trials and collaborates with healthcare professionals and research institutions to develop new treatments that address unmet medical needs. The company is committed to improving patient outcomes and enhancing the quality of life through its advanced pharmaceutical products.
Company Address: 2005 Market Street, Suite 2030 Philadelphia 19103 PA
Company Phone Number: 765-3222 Stock Exchange / Ticker: NYSE IBER
|